Skip to content

Opko Health OPK Cash ratio

Cash ratio at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
0.2×0.0×
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
1.1×-0.8×
HRO
HarrowHROW
+0.7×
Precigen logo
PrecigenPGEN
0.4×+0.1×
Immunome logo
ImmunomeIMNM
21.3×+12.9×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
0.5×+0.1×

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+10.0%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Calculated from Opko Health’s reported figures.

Based on the most recent quarter.

The official record: Opko Health’s 10-Q, filed August 7, 2024, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's cash ratio?
Opko Health (OPK) reported cash ratio of 0.2× in Q2 2024.
How has Opko Health's cash ratio changed year-over-year?
Opko Health's cash ratio decreased by 61.3% year-over-year, from 0.5× to 0.2×.
What is the long-term trend for Opko Health's cash ratio?
Over 3 years (2020 to 2023), Opko Health's cash ratio has grown at a 35.6% compound annual growth rate (CAGR), from 0.2× to 0.5×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.